tradingkey.logo

Surmodics Inc

SRDX
查看详细走势图
42.980USD
0.000
交易中 美东报价延迟15分钟
614.53M总市值
亏损市盈率 TTM

Surmodics Inc

42.980
0.000
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

0.00%

5天

0.00%

1月

0.00%

6月

+48.21%

今年开始到现在

+8.54%

1年

+8.76%

查看详细走势图

TradingKey Surmodics Inc股票评分

单位: USD 更新时间: 2025-11-19

操作建议

Surmodics Inc当前公司基本面数据相对健康,当前估值合理,机构持股占比非常高,近一月多位分析师给出公司评级为卖出。最高目标价max_target_price。近一个月,市场表现非常差,但公司基本面和技术面得分较高。

Surmodics Inc评分

相关信息

行业排名
77 / 209
全市场排名
183 / 4596
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 0 位分析师
--
评级
43.000
目标均价
+47.26%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Surmodics Inc亮点

亮点风险
Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. It also develops and commercializes highly differentiated vascular intervention medical devices that are designed to address unmet clinical needs and engineered to the demanding requirements. Its segments include Medical Device and IVD. Medical Device segment manufactures and licenses performance coatings, including surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that include neurovascular, peripheral and coronary. IVD segment manufactures chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets.
业绩高增长
公司营业收入稳步增长,连续3年增长26.14%
估值合理
公司最新PE估值0.00,处于3年历史合理位
机构减仓
最新机构持股12.95M股,环比减少24.21%
PRFDX持仓
明星投资者PRFDX持仓,最新持仓市值1.13K
活跃度增加
近期活跃度增加,过去20天平均换手率0.62

Surmodics Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Surmodics Inc简介

Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. It also develops and commercializes highly differentiated vascular intervention medical devices that are designed to address unmet clinical needs and engineered to the demanding requirements. Its segments include Medical Device and IVD. Medical Device segment manufactures and licenses performance coatings, including surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that include neurovascular, peripheral and coronary. IVD segment manufactures chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets.
公司代码SRDX
公司Surmodics Inc
CEOHance (Robert B)
网址https://www.surmodics.com/

常见问题

Surmodics Inc(SRDX)的当前股价是多少?

Surmodics Inc(SRDX)的当前股价是 42.980。

Surmodics Inc的股票代码是什么?

Surmodics Inc的股票代码是SRDX。

Surmodics Inc股票的52周最高点是多少?

Surmodics Inc股票的52周最高点是42.890。

Surmodics Inc股票的52周最低点是多少?

Surmodics Inc股票的52周最低点是25.870。

Surmodics Inc的市值是多少?

Surmodics Inc的市值是614.53M。

Surmodics Inc的净利润是多少?

Surmodics Inc的净利润为-11.54M。

现在Surmodics Inc(SRDX)的股票是买入、持有还是卖出?

根据分析师评级,Surmodics Inc(SRDX)的总体评级为--,目标价格为43.000。

Surmodics Inc(SRDX)股票的每股收益(EPS TTM)是多少

Surmodics Inc(SRDX)股票的每股收益(EPS TTM)是-1.237。
KeyAI